Glycolic acid/lactic acid copolymer obtained by ring-opening polymerization.
The "Glycolic Acid/Lactic Acid Copolymer (PGDLLA)" is obtained by using glycolide (the cyclic dimer of glycolic acid) and lactide (the cyclic dimer of lactic acid) as monomers and polymerizing them through ring-opening polymerization. Lactide can be classified into three types (L-lactide, D-lactide, and DL-lactide) due to its optical activity, so we refer to the copolymer of glycolide and DL-lactide as "PGDLLA." Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. 【Features】 ■ Obtained through ring-opening polymerization ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Insoluble (high glycolide content) *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Polymer Identification: Must match the NMR spectrum of standard PGDLLA ■ Composition: CGA:CLA = 20:80 − 30:70 (mol%) ■ Molecular Weight (MW): MW = 220,000 − 280,000 ■ Glass Transition Temperature (Tg): Tg = 50 − 60 (℃) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm * This is the specification (standard) for our representative PGDLLA polymer (PGDLLA(25:75)). * For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Uses】 ■Membrane: periodontal tissue regeneration membrane, artificial dura mater, adhesion prevention membrane, scaffold *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Institute for Frontier Medical Sciences at Kyoto University. Since its founding, the company has focused on the field of medical polymers to realize its corporate philosophy of "contributing to the health of people around the world by working on the development of better medical biomaterial products and providing innovative solutions in the medical field," supporting advancements in biomaterials technology and people's health across three business areas.